A black-box warning is not a neutral informational update. It is the FDA’s most aggressive regulatory communication via product labeling, intended to alert clinicians and patients to risks so grave ...
"The conditions of the ‘box’ ... would likely cause severe physical and psychological pain and suffering," the report read.